What is in this article?:
- Interesting collisions: Monsanto & GOED
- GOED: The world needs all the omega-3s it can get
Monsanto is a first-tier member of the Global Organization for EPA and DHA Omega- 3s (GOED). Is that surprising to you?
The story begins in September 2009, when Monsanto petitioned FDA for GRAS status over stearidonic acic (SDA) soybean oil. By inserting genes for two enzymes- one from flowers, one from bread mold- Monsanto created a soybean that converts its own alphalinolenic acid (ALA) into SDA. These acids are all omega-3s, by the way, but not every omega-3 was created equal. The human body is significantly more efficient at converting SDA into EPA and DHA- those coveted long-chain fatty acids (LCFA) linked to heart health, mental health and a host of physiological benefits- than it is converting ALA. The thinking goes that, with 375mg of SDA fortified into commercial food products, a raft of problems plaguing fish oil, from sustainability to contamination to cost, go by the wayside. In its petition, Monsanto expressed plans to introduce SDA soybean oil into cereals, puddings, grains, gravies - you name it.
"Monsanto is indeed a member," says Adam Ismail, GOED's executive director, "along with most of the other plant biotech people working on omega-3s, like Nuseed and BASF Plant Sciences. We work on EPA and DHA issues beyond just the natural products space, including pharma, infant formulas, medical devices and clinical nutrition. If you do the numbers, we will ultimately need every source of EPA and DHA to nourish the human population, including genetically modified plants." In June of this year, research sponsored by GOED, Monsanto and others, appeared in the British Journal of Nutrition pegging minimum daily intake of LCFAs at 250mg.






